Gilead Company's Medication Works Against Coronavirus

Gilead Company's Medication Works Against Coronavirus

Immediately after Gilead's drug experienced a positive development in coronavirus treatment, the company's shares began to rise on the market. Gilead Sciences Inc. immediately after news that the fever and respiratory symptoms of a group of patients in Chicago are recovering quickly. shares of the company started to rise rapidly in the markets. The drug developed by Gilead is considered one of the most followed studies in the treatment of patients with coronavirus. In patients with moderate and serious conditions under treatment, the company, which makes two different drug trials, aims to add 4 thousand people in addition to the study. The University of Chicago took 125 more patients, whose overall condition was severe. After these developments, the company's shares experienced a 10 percent increase after the closing of the markets. Recovery of almost all treated patients is important in conducting tests comparing treatments against the placebo effect. While a placebo group is included in moderate patients, Gilead does not include a placebo group in experiments conducted in serious patients.